If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...
A U.S. Centers for Medicare & Medicaid Services 18-month trial program will offer for the first time Novo Nordisk’s Wegovy ...
Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...
Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...
By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...
Amgen (AMGN) stock is in focus as an expert panel of the European Medicines Agency recommends withdrawal of the company's ...
A clinical trial used to approve Amgen Inc.’s pill Tavneos was retracted Monday from the New England Journal of Medicine, ...
The committee is recommending that no new patients start treatment with Tavneos and that existing patients be switched to ...
Zacks Investment Research on MSN
Investors heavily search Amgen Inc. (AMGN): Here is what you need to know
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...
Amgen has recalled select lots of its heart medication Corlanor and kidney disease treatment Sensipar because of foreign material concerns and current good manufacturing practice deviations. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results